Suchergebnisse - "Haslwanter, Denise"

PubPharm (38)

11

Genotype-specific Features Reduce the Susceptibility of South American Yellow Fever Virus Strains to Vaccine-Induced Antibodies

enthalten in: bioRxiv.org | 2022

von Haslwanter, D. | Lasso, G. | Wec, A. | +17

12

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

enthalten in: EBioMedicine | 2022

von Muena, N. | García-Salum, T. | Pardo-Roa, C. | +18

UpdateOf: medRxiv. 2021 May 18;:. - PMID 34031662

13

Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference

enthalten in: bioRxiv.org | 2022

von Fels, J. | Khan, S. | Forster, R. | +21

14

Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference

enthalten in: medRxiv : the preprint server for health sciences | 2022

von Fels, J. | Khan, S. | Forster, R. | +21

UpdateIn: Cold Spring Harb Mol Case Stud. 2022 Jul 13;:. - PMID 35831070

15

Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies

enthalten in: Cell host & microbe | 2022

von Haslwanter, D. | Lasso, G. | Wec, A. | +17

CommentIn: Cell Host Microbe. 2022 Feb 9;30(2):151-153. - PMID 35143767

16

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes

enthalten in: PLoS computational biology | 2022

von Lasso, G. | Khan, S. | Allen, S. | +29

17

Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response

enthalten in: Nature communications | 2021

von Herman, J. | Wang, C. | Loos, C. | +12

UpdateOf: medRxiv. 2021 Mar 11;:. - PMID 33758875

18

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

enthalten in: mBio | 2021

von Haslwanter, D. | Dieterle, M. | Wec, A. | +27

19

Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines

enthalten in: bioRxiv.org | 2021

von Muena, N. | García-Salum, T. | Pardo-Roa, C. | +17

20

Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines

enthalten in: medRxiv : the preprint server for health sciences | 2021

von Muena, N. | García-Salum, T. | Pardo-Roa, C. | +17

UpdateIn: EBioMedicine. 2022 Apr;78:103972. - PMID 35366624